Your session is about to expire
← Back to Search
Footwear
Orthofeet Shoes for Plantar Fasciitis
Phase 1 & 2
Waitlist Available
Research Sponsored by Bijan Najafi, PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 week, 6 weeks, 7 weeks, 12 weeks
Awards & highlights
Summary
This trial is testing a new type of pain-relieving footwear to see if it increases daily activity levels and improve functional performance.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 1 week, 6 weeks, 7 weeks, 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 week, 6 weeks, 7 weeks, 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Foot Pain Intensity
Change in step count from baseline to 6 weeks to 12 weeks
Secondary outcome measures
Change in Balance
Change in Cognitive Function
Change in Fear of Falling
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Orthofeet ShoesExperimental Treatment1 Intervention
Participants will be given Orthofeet shoes to wear for 6 weeks
Group II: No Orthofeet shoesActive Control1 Intervention
This group will not be wearing Orthofeet shoes for 6 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Orthofeet Shoes
2022
Completed Phase 2
~50
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Bijan Najafi, PhDLead Sponsor
4 Previous Clinical Trials
284 Total Patients Enrolled
Orthofeet, Inc.UNKNOWN
Share this study with friends
Copy Link
Messenger